share_log

Xeris Pharmaceuticals Q2 EPS $(0.19) Up From $(0.41) YoY, Sales $25.31M Miss $25.53M Estimate

Xeris Pharmaceuticals Q2 EPS $(0.19) Up From $(0.41) YoY, Sales $25.31M Miss $25.53M Estimate

Xeris PharmPharmticals第二季度每股收益為0.19美元,高於上年同期的0.41美元,銷售額為2531萬美元,錯過了2553萬美元的預期
Benzinga Real-time News ·  2022/08/10 07:10

Xeris Pharmaceuticals (NASDAQ:XERS) reported quarterly losses of $(0.19) per share. This is a 53.66 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $25.31 million which missed the analyst consensus estimate of $25.53 million by 0.88 percent. This is a 186.43 percent increase over sales of $8.84 million the same period last year.

納斯達克公司(Xeris PharmPharmticals)公佈季度每股虧損0.19美元。這比去年同期每股虧損0.41美元增加了53.66%。該公司公佈的季度銷售額為2,531萬美元,低於分析師一致預期的2,553萬美元,降幅為0.88%。這比去年同期884萬美元的銷售額增長了186.43個百分點。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論